Standard Biotools (LAB) Share-based Compensation (2010 - 2026)

Standard Biotools (LAB) has reported Share-based Compensation for 17 consecutive years, with $33.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation fell 6.45% year-over-year to $33.1 million in Q2 2026; TTM through Jun 2026 was $33.1 million, a 6.45% decrease from a year earlier, with the FY2025 full-year figure at $32.5 million, down 17.0% from the prior year.
• Share-based Compensation was $33.1 million for Q2 2026 at Standard Biotools, down from $36.4 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $37.6 million in Q1 2025 and troughed at $1.7 million in Q4 2022.
• A 5-year average of $13.5 million and a median of $5.2 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 61.71% in 2022 and soared 939.15% in 2025, its largest moves.
• Over 5 years, Share-based Compensation stood at $1.7 million in 2022, then soared by 106.72% to $3.5 million in 2023, then surged by 114.96% to $7.5 million in 2024, then decreased by 23.12% to $5.7 million in 2025, then surged by 477.21% to $33.1 million in 2026.
• The last three Share-based Compensation figures came in at $33.1 million (Q2 2026), $36.4 million (Q1 2026), and $5.7 million (Q4 2025), per Business Quant data.